Targeted prostate cancer treatment cuts risk of side effects, study suggests

An NHS trial over 10 years followed nearly 3,500 men who received focal therapy, a less invasive treatment.

About the Author

has written 41913 stories on this site.

Copyright © 2010 Business and Corporate News.